295.49
price down icon0.17%   -0.1042
 
loading
Precedente Chiudi:
$295.59
Aprire:
$296
Volume 24 ore:
231.70K
Relative Volume:
0.63
Capitalizzazione di mercato:
$32.35B
Reddito:
$3.81B
Utile/perdita netta:
$-644.79M
Rapporto P/E:
-47.35
EPS:
-6.24
Flusso di cassa netto:
$-669.77M
1 W Prestazione:
+5.70%
1M Prestazione:
+14.59%
6M Prestazione:
+32.78%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$294.44
$299.70
Intervallo di 1 settimana:
Value
$287.33
$300.00
Portata 52W:
Value
$172.67
$300.00

Beone Medicines Ltd Adr Stock (ONC) Company Profile

Name
Nome
Beone Medicines Ltd Adr
Name
Telefono
13459494123
Name
Indirizzo
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
Name
Dipendente
11,000
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ONC's Discussions on Twitter

Confronta ONC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.20 29.19B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
478.74 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.25 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.47 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
570.09 34.02B 2.58B 1.06B -1.28B 16.33

Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-07 Iniziato RBC Capital Mkts Outperform
2025-03-03 Aggiornamento BofA Securities Neutral → Buy
2024-12-03 Ripresa Morgan Stanley Overweight
2024-09-18 Iniziato JMP Securities Mkt Outperform
2024-02-06 Ripresa JP Morgan Overweight
2023-09-12 Iniziato Macquarie Outperform
2023-08-17 Iniziato Jefferies Buy
2023-07-17 Iniziato Citigroup Buy
2023-06-30 Downgrade Bernstein Outperform → Mkt Perform
2023-01-12 Iniziato Daiwa Securities Buy
2022-10-13 Aggiornamento Guggenheim Neutral → Buy
2022-10-13 Aggiornamento SVB Leerink Mkt Perform → Outperform
2022-08-09 Ripresa JP Morgan Overweight
2022-03-17 Downgrade SVB Leerink Outperform → Mkt Perform
2022-02-07 Iniziato Deutsche Bank Buy
2021-10-12 Iniziato Bernstein Outperform
2021-10-06 Aggiornamento CLSA Underperform → Buy
2021-03-08 Iniziato China Renaissance Buy
2021-03-01 Downgrade CLSA Outperform → Underperform
2020-11-09 Downgrade Ladenburg Thalmann Buy → Neutral
2020-11-06 Downgrade Maxim Group Buy → Hold
2020-11-06 Downgrade Piper Sandler Neutral → Underweight
Mostra tutto

Beone Medicines Ltd Adr Borsa (ONC) Ultime notizie

pulisher
Jul 19, 2025

BeOne Medicines Ltd.Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains? - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week High Following Analyst Upgrade - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 15, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap UpTime to Buy? - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 08, 2025
pulisher
Jun 30, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat

Jun 30, 2025
pulisher
Jun 29, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% Following Insider Selling - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

BeOne Medicines (NASDAQ:ONC) Receives “Outperform” Rating from Royal Bank Of Canada - Defense World

Jun 28, 2025
pulisher
Jun 28, 2025

Insider Selling: BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) COO Sells 1,363 Shares of Stock - MarketBeat

Jun 28, 2025
pulisher
Jun 27, 2025

BeOne Medicines (NASDAQ:ONC) Shares Down 3.6% After Insider Selling - Defense World

Jun 27, 2025
pulisher
Jun 17, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 5.4%Here's What Happened - MarketBeat

Jun 17, 2025
pulisher
Jun 13, 2025

Entergy Corp’s Shares Reel: 0.54% Quarterly Revenue Decline Amid 35.88B Market Cap - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

BeOne Medicines Ltd ADR (ONC) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 13, 2025
pulisher
Jun 05, 2025

Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily

Jun 05, 2025
pulisher
Jun 03, 2025

LLY Stock Quote Price and Forecast - CNN

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright maintains neutral rating on Zymeworks stock - Investing.com India

Jun 02, 2025
pulisher
May 31, 2025

China approves novel HER2-targeted therapy for BTC By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge By Stocktwits - Investing.com India

May 30, 2025
pulisher
May 30, 2025

China approves novel HER2-targeted therapy for BTC - Investing.com Australia

May 30, 2025
pulisher
May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland - Investing.com

May 27, 2025
pulisher
May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 26, 2025

Daiwa Raises BEIGENE's TP to HKD180; Brukinsa Sales Growth Outpaces Competitors - AASTOCKS.com

May 26, 2025
pulisher
May 21, 2025

BeiGene Shareholders Approve Director Elections and Auditors By Investing.com - Investing.com India

May 21, 2025
pulisher
May 13, 2025

Daiwa Sees Limited Upside for HSI, Prefers HK Stocks w/ Tech Trading Opportunities Like BEIGENE - AASTOCKS.com

May 13, 2025
pulisher
May 08, 2025

Market Momentum: BeiGene Ltd. ADR (ONC) Registers a -3.93 Decrease, Closing at 232.25 - DWinneX

May 08, 2025
pulisher
May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

BeiGene wins US patent dispute over cancer drug By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

Universal Health Q1 Earnings Beat on Strong Acute Care Admissions - Zacks Investment Research

Apr 29, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP - Investing.com

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Apr 24, 2025
pulisher
Apr 21, 2025

BigBear.ai Holdings Inc (BBAI) gets rating Downgrade from Northland Capital - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Morgan Stanley analysts upgrades an Equal-weight rating for Urban Edge Properties (UE) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

RBC Capital Mkts initates BeiGene Ltd. ADR (ONC) rating to an Outperform - knoxdaily.com

Apr 21, 2025
pulisher
Apr 17, 2025

BGNE Page Not Found - Benzinga

Apr 17, 2025

Beone Medicines Ltd Adr Azioni (ONC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$570.30
price down icon 0.24%
$113.60
price up icon 1.92%
$327.47
price up icon 0.72%
$27.68
price up icon 4.45%
$102.81
price down icon 0.20%
Capitalizzazione:     |  Volume (24 ore):